Cargando…

P1664: IMPACT OF A PROTOCOL USING RITUXIMAB FOR PREVENTION OF RELAPSE IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP)

Detalles Bibliográficos
Autores principales:	Marín Sánchez, E., Fernandes, E., López Marín, J., Tarín, F., Hernandez Mateo, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430794/ http://dx.doi.org/10.1097/01.HS9.0000849512.36608.fe

Ejemplares similares

Relapsed Refractory Acquired Thrombotic Thrombocytopenic Purpura (aTTP) Following COVID-19 Vaccination
por: Francisco, Michael T., et al.
Publicado: (2021)

Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura
por: Chen, Haifei, et al.
Publicado: (2017)

Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without Rituximab
por: Falter, Tanja, et al.
Publicado: (2018)

mRNA-1273: Relapsed acquired thrombotic thrombocytopenic purpura: case report
Publicado: (2022)

Efficacy and Safety of Rituximab for Refractory and Relapsing Thrombotic Thrombocytopenic Purpura: A Cohort of 10 Cases
por: Omri, Halima El, et al.
Publicado: (2015)

Thrombotic thrombocytopenic purpura treated with rituximab in systemic lupus erythematosus
por: Karimifar, Mansoor
Publicado: (2012)

A Novel Case of Cytomegalovirus Pneumonia in an Acquired Thrombotic Thrombocytopenic Purpura Patient Treated With Rituximab
por: Kandah, Emad, et al.
Publicado: (2021)

Positive Response and Increase in ADAMTS13 with Scheduled Rituximab in a Patient with Relapsing Thrombotic Thrombocytopenic Purpura
por: Amer, Bahaa, et al.
Publicado: (2019)

Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018)

Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura
por: Hanlon, Ashley, et al.
Publicado: (2020)

Tozinameran: Acquired thrombotic thrombocytopenic purpura: case report
Publicado: (2022)

Ribosomal and Immune Transcripts Associate with Relapse in Acquired ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura
por: Edgar, Contessa E., et al.
Publicado: (2015)

Thrombotic thrombocytopenic purpura after an episode of acute pancreatitis
por: Giannini, F, et al.
Publicado: (2005)

Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023)

Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine
por: Sissa, Cinzia, et al.
Publicado: (2021)

The Long and Winding Road for New Treatments for Acquired Thrombotic Thrombocytopenic Purpura
por: Schutgens, Roger E.G.
Publicado: (2019)

Acquired Thrombotic Thrombocytopenic Purpura in a Patient with Pernicious Anemia
por: Pandey, Ramesh Kumar, et al.
Publicado: (2017)

Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura
por: Elverdi, Tugrul, et al.
Publicado: (2019)

Tozinameran: Acquired thrombotic thrombocytopenic purpura: 4 case reports
Publicado: (2021)

AZD-1222: Acquired thrombotic thrombocytopenic purpura: case report
Publicado: (2022)

Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura: A case report
por: Chaurasiya, Prem Shankar, et al.
Publicado: (2022)

Thrombotic Thrombocytopenic Purpura and Gemcitabine
por: Kasi, Pashtoon Murtaza
Publicado: (2011)

Dengue and Thrombotic Thrombocytopenic Purpura
por: Wiwanitkit, Viroj
Publicado: (2017)

Vaccination and Thrombotic Thrombocytopenic Purpura
por: Yavaşoğlu, İrfan
Publicado: (2020)

Caplacizumab for thrombotic thrombocytopenic purpura
Publicado: (2020)

Hereditary Thrombotic Thrombocytopenic Purpura
por: Nusrat, Sanober, et al.
Publicado: (2023)

Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic Purpura
por: Little, Dustin J., et al.
Publicado: (2017)

Tozinameran: Relapse of immune-mediated thrombotic thrombocytopenic purpura: case report
Publicado: (2022)

Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura()
por: Thomas, Mari R., et al.
Publicado: (2015)

Dramatic presentation of acquired thrombotic thrombocytopenic purpura associated with COVID-19
por: Capecchi, Marco, et al.
Publicado: (2020)

Clinical Efficacy and Safety Profile of Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
por: Maqsood, Muhammad Haisum, et al.
Publicado: (2019)

Acquired thrombotic thrombocytopenic purpura following Pfizer COVID‐19 vaccination
por: Alislambouli, Mawaddah, et al.
Publicado: (2021)

Rituximab Prevents Stroke Recurrences in Atypical Chronic Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Dupuy, Henry, et al.
Publicado: (2018)

Thrombotic Thrombocytopenic Purpura Treated with Rituximab Associated with Primary Sjögren's Syndrome and Primary Hypothyroidism
por: Okumura, Taiki, et al.
Publicado: (2019)

Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab
por: Abou-Ismail, Mouhamed Yazan, et al.
Publicado: (2020)

5599228 PITFALLS IN DIAGNOSING THROMBOTIC THROMBOCYTOPENIC PURPURA IN SICKLE CELL DISEASE
por: TSITSIKAS, D.A., et al.
Publicado: (2023)

Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis, Rituximab, Cyclophosphamide and Splenectomy
por: Musa, Faisal, et al.
Publicado: (2015)

Relapsed/refractory acquired thrombotic thrombocytopenic purpura in a patient with Sjögren syndrome: Case report and review of the literature
por: Sun, Rurong, et al.
Publicado: (2018)

Thrombotic Thrombocytopenic Purpura Associated with Pazopanib
por: Syed, Umer, et al.
Publicado: (2018)

Novel therapies in thrombotic thrombocytopenic purpura
por: Masias, Camila, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ukcskokovevtmsp22ste66jfev